Secretomes from Mesenchymal Stem Cells Against Acute Kidney Injury: Possible Heterogeneity

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2019 Jan 18

PMID 30651737

Citations 33

Authors

Kenji Tsuji

Shinji Kitamura

Jun Wada

Affiliations

Soon will be listed here.

Abstract

A kidney has the ability to regenerate itself after a variety of renal injuries. Mesenchymal stem cells (MSCs) have been shown to ameliorate tissue damages during renal injuries and diseases. The regenerations induced by MSCs are primarily mediated by the paracrine release of soluble factors and extracellular vesicles, including exosomes and microvesicles. Extracellular vesicles contain proteins, microRNAs, and mRNAs that are transferred into recipient cells to induce several repair signaling pathways. Over the past few decades, many studies identified trophic factors from MSCs, which attenuate renal injury in a variety of animal acute kidney injury models, including renal ischemia-reperfusion injury and drug-induced renal injury, using microarray and proteomic analysis. Nevertheless, these studies have revealed the heterogeneity of trophic factors from MSCs that depend on the cell origins and different stimuli including hypoxia, inflammatory stimuli, and aging. In this review article, we summarize the secretomes and regenerative mechanisms induced by MSCs and highlight the possible heterogeneity of trophic factors from different types of MSC and different circumstances for renal regeneration.

Citing Articles

Comparative study of systemic and local delivery of mesenchymal stromal cells for the treatment of chronic kidney disease.

Gregersen E, Kresse J, Atay J, Boysen A, Nejsum P, Eijken M Front Cell Dev Biol. 2024; 12:1456416.

PMID: 39234562 PMC: 11373351. DOI: 10.3389/fcell.2024.1456416.

Subcutaneous injection of adipose stromal cell-secretome improves renal function and reduces inflammation in established acute kidney injury.

Ullah M, Collett J, Monroe J, Traktuev D, Coleman M, March K Stem Cell Res Ther. 2024; 15(1):119.

PMID: 38659070 PMC: 11040889. DOI: 10.1186/s13287-024-03736-x.

MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury.

Tsuji K, Nakanoh H, Fukushima K, Kitamura S, Wada J Diagnostics (Basel). 2023; 13(18).

PMID: 37761260 PMC: 10529274. DOI: 10.3390/diagnostics13182893.

Detrimental alteration of mesenchymal stem cells by an articular inflammatory microenvironment results in deterioration of osteoarthritis.

Fan M, Tong P, Yan L, Li T, Ren J, Huang J BMC Med. 2023; 21(1):215.

PMID: 37337188 PMC: 10280917. DOI: 10.1186/s12916-023-02923-6.

Long-Term Effects of Severe Burns on the Kidneys: Research Advances and Potential Therapeutic Approaches.

Yang G, Tan L, Yao H, Xiong Z, Wu J, Huang X J Inflamm Res. 2023; 16:1905-1921.

PMID: 37152866 PMC: 10162109. DOI: 10.2147/JIR.S404983.

References

Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-7. DOI: 10.1126/science.284.5411.143. View

Potian J, Aviv H, Ponzio N, Harrison J, Rameshwar P . Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol. 2003; 171(7):3426-34. DOI: 10.4049/jimmunol.171.7.3426. View

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Wang D, Park J, Chu J, Krakowski A, Luo K, Chen D . Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem. 2004; 279(42):43725-34. DOI: 10.1074/jbc.M407368200. View

Aggarwal S, Pittenger M . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2004; 105(4):1815-22. DOI: 10.1182/blood-2004-04-1559. View

Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C . Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005; 289(1):F31-42. DOI: 10.1152/ajprenal.00007.2005. View

Groh M, Maitra B, Szekely E, Koc O . Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol. 2005; 33(8):928-34. DOI: 10.1016/j.exphem.2005.05.002. View

Broekema M, Harmsen M, Koerts J, Petersen A, van Luyn M, Navis G . Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/reperfusion in rats. Kidney Int. 2005; 68(6):2572-81. DOI: 10.1111/j.1523-1755.2005.00728.x. View

Liu C, Hwang S . Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine. 2005; 32(6):270-9. DOI: 10.1016/j.cyto.2005.11.003. View

10.

Caplan A, Dennis J . Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98(5):1076-84. DOI: 10.1002/jcb.20886. View

11.

Moseley T, Zhu M, Hedrick M . Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg. 2006; 118(3 Suppl):121S-128S. DOI: 10.1097/01.prs.0000234609.74811.2e. View

12.

Kolf C, Cho E, Tuan R . Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9(1):204. PMC: 1860068. DOI: 10.1186/ar2116. View

13.

Mott J, Kobayashi S, Bronk S, Gores G . mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene. 2007; 26(42):6133-40. PMC: 2432524. DOI: 10.1038/sj.onc.1210436. View

14.

Kilroy G, Foster S, Wu X, Ruiz J, Sherwood S, Heifetz A . Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol. 2007; 212(3):702-9. DOI: 10.1002/jcp.21068. View

15.

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

16.

Tsai M, Hwang S, Chen K, Lee Y, Hsu L, Chang Y . Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells. 2007; 25(10):2511-23. DOI: 10.1634/stemcells.2007-0023. View

17.

Sze S, de Kleijn D, Lai R, Tan E, Zhao H, Yeo K . Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics. 2007; 6(10):1680-9. DOI: 10.1074/mcp.M600393-MCP200. View

18.

Johnson C, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D . The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 2007; 67(16):7713-22. DOI: 10.1158/0008-5472.CAN-07-1083. View

19.

Filipowicz W, Bhattacharyya S, Sonenberg N . Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008; 9(2):102-14. DOI: 10.1038/nrg2290. View

20.

Crisostomo P, Wang Y, Markel T, Wang M, Lahm T, Meldrum D . Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008; 294(3):C675-82. DOI: 10.1152/ajpcell.00437.2007. View